SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007341
Filing Date
2023-03-10
Accepted
2023-03-10 17:01:10
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K life-20230310.htm   iXBRL 8-K 63039
  Complete submission text file 0000950170-23-007341.txt   180660

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230310_lab.xml EX-101.LAB 13352
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230310.xsd EX-101.SCH 2470
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230310_pre.xml EX-101.PRE 10992
6 EXTRACTED XBRL INSTANCE DOCUMENT life-20230310_htm.xml XML 4708
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 23724553
SIC: 2836 Biological Products, (No Diagnostic Substances)